Search results
Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine
Zacks via Yahoo Finance· 3 days agoIt expects to generate around $4 billion in product revenues, driven mainly by the sales of its...
While shareholders of Moderna (NASDAQ:MRNA) are in the black over 5 years, those who bought a week...
Simply Wall St. via Yahoo Finance· 3 days agoIf you are thinking of buying or selling Moderna stock, you should check out this free report...
Novavax, Nvidia, Sweetgreen rise premarket; Moderna, Yelp fall By Investing.com
Investing.com· 6 days agoNovavax, Nvidia, Sweetgreen rise premarket; Moderna, Yelp fall
Top Stock Movers Now: TSMC, Moderna, Sweetgreen, and More
Investopedia· 6 days agoU.S. equities were mixed at midday, as the markets reacted to corporate headlines and report showing...
Bull Market and Beyond: 2 Stocks Just Waiting to Soar
Motley Fool via Yahoo Finance· 3 days agoWith those opportunities ahead, DexCom's future looks bright. Investors with a long-term focus can...
Moderna says FDA will not complete review of RSV vaccine by May 12 deadline
Market Watch· 6 days agoModerna Inc.’s stock fell 2.6% Friday, after the company said the Food and Drug Administration will...
Moderna shares target raised to $85 by Deutsche Bank By Investing.com
Investing.com· 6 days agoThe adjustment follows a review of Moderna's first-quarter performance, which reported steady...
Stock Market Today: Dow rides broadening out of rally to notch 4th weekly win By Investing.com
Investing.com· 6 days agoInvesting.com-- The Dow closed higher Friday to clinch its fourth-weekly win as the broadening out...
Moderna Stock Slips as FDA Delays RSV Vaccine Approval
Investopedia· 6 days agoModerna (MRNA) shares lost ground in intraday trading Friday as the biotech’s effort to move beyond...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 12 hours agoLike other early-stage biotech companies, Gyre has reported years of annual losses, though came in...